Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences
· biogen inc.
AI Briefing
- Biogen to share new SMA data at Muscular Dystrophy Association and SMA Europe conferences.
- Company will present updates from its spinal muscle atrophy research programs.
- Presentations will include high dose nusinersen and salanersen trials.
Advertisement